KVUE241227C21000
- 0.66
- 0.000.00%
Kenvue Newsroom
FDA Proposes Testing Talc Products for Asbestos: Report
Unusual Options Activity: AMCR, KVUE and Others Attract Market Bets, AMCR V/OI Ratio Reaches 599.2
EST Dec 20th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
After GE's Spinoff Success, What's Next for Honeywell, FedEx
Peering Into Kenvue's Recent Short Interest
Daily short sale tracking: Warner Bros Discovery's short volume increased by 10 million, with a short sale ratio of 16%
Warner Bros Discovery(WBD.US) ranked top of the list had the largest change in short volume (10.01 million shares), and the short volume ratio of South Bow(SOBO.US) reached 58.62%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.
Jefferies Maintains Kenvue(KVUE.US) With Buy Rating, Maintains Target Price $27
Kenvue, Inc.: Strategic Growth Drivers and Market Positioning Justify Buy Rating
Kenvue Initiated at Equal-Weight by Barclays
Barclays Maintains Kenvue(KVUE.US) With Hold Rating, Maintains Target Price $23
An Intrinsic Calculation For Kenvue Inc. (NYSE:KVUE) Suggests It's 33% Undervalued
Barclays Initiates Kenvue(KVUE.US) With Hold Rating, Announces Target Price $23
Starboard Nominates Five Directors To Kenvue's Board
Kenvue Cut to Hold From Buy by Deutsche Bank
Kenvue Analyst Ratings
Deutsche Bank Downgrades Kenvue(KVUE.US) to Hold Rating, Maintains Target Price $24
Express News | Kenvue Inc : HSBC Raises Target Price to $23 From $21
CCORF Maintains Kenvue(KVUE.US) With Buy Rating, Maintains Target Price $27
Kenvue's Post-Separation Growth and Strategic Investments Justify Buy Rating
How Is Kenvue's Stock Performance Compared to Other Consumer Defensive Stocks
RBC Capital Upgrades Kenvue(KVUE.US) to Buy Rating, Maintains Target Price $24